NCT03558087 · Interventional trial
Gemcitabine, Cisplatin, Plus Nivolumab in Patients With Muscle-invasive Bladder Cancer With Selective Bladder Sparing
Overall registry status Completed
Phase 2
Conditions Bladder Cancer
Delaware Valley sites
- Penn Medicine Abramson Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory